"Receptors, Opioid, mu" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
MeSH Number(s)
D12.776.543.750.100.620.550
D12.776.543.750.720.600.610.550
D12.776.543.750.750.555.610.550
Concept/Terms
Receptors, Opioid, mu- Receptors, Opioid, mu
- Opioid Receptors, mu
- mu Opioid Receptors
- Receptors, mu Opioid
- Receptors, mu
- mu Receptor
- Receptor, mu
- mu Receptors
- mu Opioid Receptor
- Opioid Receptor, mu
- Receptor, mu Opioid
Morphine Receptor- Morphine Receptor
- Receptor, Morphine
- Receptors, Morphine
- Morphine Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Opioid, mu".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Opioid [D12.776.543.750.100.620]
- Receptors, Opioid, mu [D12.776.543.750.100.620.550]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Opioid [D12.776.543.750.720.600.610]
- Receptors, Opioid, mu [D12.776.543.750.720.600.610.550]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Opioid [D12.776.543.750.750.555.610]
- Receptors, Opioid, mu [D12.776.543.750.750.555.610.550]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Opioid, mu".
This graph shows the total number of publications written about "Receptors, Opioid, mu" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Opioid, mu" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 3 | 3 |
| 1992 | 0 | 3 | 3 |
| 1993 | 1 | 2 | 3 |
| 1994 | 2 | 1 | 3 |
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 4 | 7 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 3 | 6 |
| 1999 | 3 | 0 | 3 |
| 2000 | 3 | 1 | 4 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 5 | 3 | 8 |
| 2004 | 2 | 2 | 4 |
| 2005 | 5 | 1 | 6 |
| 2006 | 1 | 3 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 3 | 1 | 4 |
| 2009 | 3 | 3 | 6 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 7 | 2 | 9 |
| 2013 | 5 | 6 | 11 |
| 2014 | 0 | 1 | 1 |
| 2015 | 7 | 0 | 7 |
| 2016 | 1 | 1 | 2 |
| 2017 | 5 | 1 | 6 |
| 2018 | 5 | 2 | 7 |
| 2019 | 3 | 3 | 6 |
| 2020 | 3 | 1 | 4 |
Below are the most recent publications written about "Receptors, Opioid, mu" by people in Profiles.
-
Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward. J Neurosci. 2020 11 11; 40(46):8853-8869.
-
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence. Drug Alcohol Depend. 2020 11 01; 216:108310.
-
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules. 2020 Jun 06; 25(11).
-
Dual µ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain. Eur J Pharmacol. 2020 Jun 05; 876:173062.
-
An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence. Pharmacogenomics J. 2020 10; 20(5):672-680.
-
Enhancement of Opioid Antinociception by Nicotine. J Pharmacol Exp Ther. 2019 12; 371(3):624-632.
-
Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. J Pharmacol Exp Ther. 2019 11; 371(2):544-554.
-
Alternative splicing of the Wnt trafficking protein, Wntless and its effects on protein-protein interactions. BMC Mol Cell Biol. 2019 07 08; 20(1):22.
-
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology. 2019 11 01; 158:107609.
-
Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. J Clin Invest. 2019 03 26; 129(7):2730-2744.